Spearheading Scientific Progress

We are supporting the rejuvenation biotechnology industry with a diverse range of projects.

LEAF have launched a number of projects designed to support the development of therapies focused on age-related diseases as well as providing educational opportunities for the community.


In 2016 we launched the Journal Club, a monthly science show where we discuss the latest cutting-edge research hosted by Dr. Oliver Medvedik LEAF Vice President and Director of the Maurice Kanbar Center for Biomedical Engineering.

Each month Oliver and guests review and discuss a recent journal publication live on our Facebook page and the audience watching from home can join in and ask questions too.


In 2015, inspired by the rising popularity of crowdfunding platforms such as Kickstarter and Indiegogo, we created our unique research crowdfunding platform Lifespan.io, which supports projects focused on the aging processes in order to delay, prevent, or cure age-related diseases.

To date, we have raised more than $200,000 for research on aging thanks to the support of the community, and a number of those projects have already started to bear fruit, such as the AgeMeter biomarker system, which is available now, and the MouseAge visual biomarker system, which is available free via the Apple Store.

We will continue to support cutting-edge research projects that may fall foul of the traditional grant system due to the culture of risk aversion, so check Lifespan.io often to see what new project launches are coming up and how you can get involved.


In 2018, we launched the Rejuvenation Roadmap, a project to create a curated database that would record and track the progress of the various promising research projects in our field, thus making it easier for people to see how far any given project has come. We are constantly updating and adding to the database as new companies and therapies come online, and we chart their progress to put all the information you need in one convenient place.


In 2018, we created the Longevity Investor Network, a group of forward-thinking investors who are interested in this promising field, see potential in rejuvenation therapies, and are helping the industry grow. At its monthly meetings, new biotech startups and established companies with new projects pitch their ideas to the investors; presentations from the companies are followed by Q&A rounds and discussion.

This group gives companies the opportunity to get critical investment funding in order to move their therapies towards the clinic, helping to bridge the valley of death between initial therapeutic candidates and commercial release. If you are an investor and interested in joining the group, visit the project page and get in touch.


In order to bring an end to age-related diseases, it is necessary for people from all walks of life to unite in a single international initiative. The first critical step on this path is to disseminate evidence-based knowledge about aging and rejuvenation among the general public, including the business sector and philanthropists.

The goal is to attract more resources to aging research and ensure that rejuvenation therapies are developed as soon as possible. Public awareness of the potential of these technologies will also lead to more initiatives to improve governmental legislation regulating the development, registration, and equal access to innovative interventions that address the mechanisms of aging. To achieve this goal, LEAF engages in a variety of educational activities.